Heidelberg Pharma Announces Financial Figures for Fiscal Year 2021 and Provides Business Update
• Start of clinical trial with HDP-101 in multiple myeloma
• Signing of strategic partnership with Huadong Medicine
• Successful financing activities
• Financial figures in line with adjusted forecast
• Conference call to be held on 24 March 2022 at 3:00 p.m. CET
Heidelberg Pharma AG today published its financial results and Annual Report for fiscal year 2021 (1 December 2020 – 30 November 2021) and its outlook for 2022.